Upcoming IPOs: Akums Drugs, Orient Tech, 2 other firms get SEBI nod to float public offers
These companies had filed their preliminary IPO papers with Sebi in February. The regulators observations were obtained from June 29 to July 2, 2024, according to the update. Shares of these four companies will be listed on BSE and NSE.
Capital market regulator Securities and Exchange Board of India (SEBI) has approved four companies to raise money through initial public offering (IPO), according to an update with the markets regulator on Monday, July 8.
These companies include Akums Drugs and Pharma, Gold Plus Glass, Ceigall India Limited, and Orient Technologies.
Let's know more about these companies and their funding plans.
These companies had filed their preliminary IPO papers with Sebi in February. The regulator's observations were obtained from June 29 to July 2, 2024, according to the update. Shares of these four companies will be listed on BSE and NSE.
Akums Drugs gets Sebi's nod to float IPO
Going by the draft papers of Akums Drugs and Pharmaceuticals, the IPO is a combination of a fresh issue of equity shares worth Rs 680 crore and an offer-for-sale (OFS) of 1.86 crore shares by promoters and an existing investor.
Those selling shares in the OFS are Sanjeev Jain, Sandeep Jain and Ruby QC Investment Holdings Pte Ltd.
Proceeds from the fresh issue will be used to repay debt, fund working capital requirements of the company, pursue inorganic growth initiatives through acquisition, and for general corporate purposes.
Founded in 2004, Akums is a pharmaceutical contract development and manufacturing organisation (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.
Gold Plus Glass IPO
The public issue of Float glassmaker Gold Plus Glass Industry is a mix of equity shares aggregating up to Rs 500 crore and an offer-for-sale (OFS) of up to 1.56 crore shares by promoters and investor shareholders -- Suresh Tyagi, Jimmy Tyagi, PI Opportunities Fund-I and Kotak Special Situations Fund.
The Delhi-based company is one of the leading float glassmakers in India, with 22 per cent share of manufacturing capacity as of September 2023.
The company's products cater to a range of end-use industries including automotive, construction, and industrial sectors, with a variety of applications.
In April 2022, the company filed draft papers with Sebi to raise funds through an IPO. The firm received the regulator's nod to float the issue too but didn't launch it.
Ceigall India IPO
The IPO of infrastructure company Ceigall India is a combination of a fresh issue of Rs 617.69 crore and an Offer For Sale (OFS) of up to 1.43 crore equity shares by the promoters, and an individual selling shareholder.
The offer includes a reservation for subscription by eligible employees.
Founded in 2002, Ceigall India is an infrastructure construction company with experience in undertaking specialised structural work such as elevated roads, flyovers, bridges, railway over bridges, tunnels, highways, expressways, and runways.
As of January 2024, the company's order book stood at Rs 9,206.42 crore, with NHAI contributing 82 per cent of the order book.
Orient Technologies IPO
As per the Draft Red Herring Prospectus (DRHP) of IT solutions provider Orient Technologies, the initial share sale is a combination of a fresh issue of Rs 120 crore and an Offer For Sale of up to 46 lakh equity shares by promoters.
Those offloading shares in the OFS are Ajay Baliram Sawant, Umesh Navnitlal Shah, Ujwal Arvind Mhatre, and Jayesh Manharlal Shah.
Over the years, the company has developed deep expertise in creating products and solutions for specialised disciplines across IT Infrastructure, IT Enabled Services (IteS), and Cloud and Data Management Services.
With agency inputs
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.